ArticleHepatobiliary surgery and nutrition2021

Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma.

Bo-Han Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.